First Tracks Biotherapeutics Ordinary Shares When-Issued PEG Ratio

First Tracks Biotherapeutics Ordinary Shares When-Issued (TRAXV) currently reports a PEG ratio of 45.5. That is above the Healthcare sector average of 11.77. Use the charts on this page to explore First Tracks Biotherapeutics Ordinary Shares When-Issued's PEG ratio history and peer comparisons.

First Tracks Biotherapeutics Ordinary Shares When-Issued's PEG ratio of 45.5 is higher than the Healthcare sector average of 11.77. That is roughly 286.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates First Tracks Biotherapeutics Ordinary Shares When-Issued's market price to a fundamental measure such as earnings, sales, or book value. At 45.5, TRAXV can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 45.5, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.77. From there, open related valuation or income-statement pages for First Tracks Biotherapeutics Ordinary Shares When-Issued, and consider following TRAXV for alerts when major investors trade the stock.

First Tracks Biotherapeutics Ordinary Shares When-Issued is classified in the Healthcare sector. On PEG ratio, it currently shows 45.5 versus a sector average near 11.77. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TRAXV with unrelated industries.